Boji Medical Technology News

Boji Pharmaceutical: 2021 Annual Equity Distribution Implementation Notice

May 25, 2022 12:00 ET

Boji Pharmaceutical: Announcement on the acquisition of some minority shareholders' shares of the holding subsidiary Hong Kong Yonghe Technology Co., Ltd. (2021-012)

Apr 16, 2021 12:00 ET

Boji Pharmaceutical: Prompt announcement on planning to acquire some minority shareholders' shares of the holding subsidiary Hong Kong Yonghe Technology Co., Ltd.

Dec 10, 2020 11:00 ET

Boji Pharmaceutical: Beijing Kangda Law Firm's Supplementary Legal Opinion on Guangzhou Boji Pharmaceutical Biotechnology Co., Ltd.'s Issuance of A-Shares to Specific Targets (2)

Nov 2, 2020 11:00 ET

Boji Pharmaceutical: Response report of Guangzhou Boji Pharmaceutical Biotechnology Co., Ltd. and CITIC Securities Co., Ltd. on the implementation letter of feedback on the registration process of Guangzhou Boji Pharmaceutical Biotechnology Co., Ltd.'s app

Nov 2, 2020 11:00 ET

Boji Pharmaceutical: Issuance of registration process feedback implementation letter

Oct 20, 2020 12:00 ET

Boji Pharmaceutical: 6-20-7 ZTE Certified Public Accountants (Special General Partnership) “Response Report to the Audit Center's Opinion Implementation Letter on Guangzhou Boji Pharmaceutical Biotechnology Co., Ltd.'s Application for Issuance of Shares to

Sep 20, 2020 12:00 ET

Boji Pharmaceutical: 6-20-6 Response Report to the Audit Center Opinion Implementation Letter on Guangzhou Boji Pharmaceutical Biotechnology Co., Ltd.'s Application for Issuance of Shares to Specific Targets (Revised Draft)

Sep 20, 2020 12:00 ET

Hakusai Pharmaceutical: 1-1 Application Instructions (Application Draft)

Aug 16, 2020 12:00 ET

Boji Pharmaceutical: Implementation letter from the Audit Center on Guangzhou Boji Pharmaceutical Biotechnology Co., Ltd.'s application to issue shares to specific targets

Aug 15, 2020 12:00 ET

Boji Pharmaceutical: 1. Response report of Guangzhou Boji Pharmaceutical Biotechnology Co., Ltd. and CITIC Securities Co., Ltd. to the audit inquiry letter of Guangzhou Boji Pharmaceutical Biotechnology Co., Ltd.'s application to issue shares to specific t

Jul 23, 2020 12:00 ET

Boji Pharmaceutical: Audit inquiry letter on Guangzhou Boji Pharmaceutical Biotechnology Co., Ltd.\'s application to issue shares to specific targets

Jul 9, 2020 12:00 ET

Boji Pharmaceutical: 6-1 The issuer's financial report for the most recent year and its audit report, and the most recent financial report (report)

Jun 29, 2020 12:00 ET

Hakuji Pharmaceutical: 4-1 Legal Opinion (Report Draft)

Jun 29, 2020 12:00 ET

Boji Pharmaceutical: 3-3 Listing Sponsorship Letter (Application Draft)

Jun 29, 2020 12:00 ET

Boji Pharmaceutical: 3-1 Securities Issuance Sponsorship Letter (Declaration Draft)

Jun 29, 2020 12:00 ET

Hakusai Pharmaceutical: 1-1 Application Instructions (Application Draft)

Jun 29, 2020 12:00 ET

Boji Pharmaceutical: Announcement on the proposed purchase of office space

May 11, 2016 12:00 ET

Boji Pharmaceutical: China Securities Regulatory Commission's approval for the company's initial public offering of shares

Apr 2, 2015 12:00 ET